Juan C. Jaen, SVP, Drug Discovery & CSO at ChemoCentryx, Inc. (CCXI), sold 2,795 shares at $13.95 ($39K) on 2013-03-07, disclosed to the SEC on 2013-03-11.
Scheduled sale ($39k) by SVP, Drug Discovery & CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.95 | 700 | $10K | 25.0% |
| 2 | $13.98 | 2,095 | $29K | 75.0% |
| Total | $13.97 avg | 2,795 | $39K | 100% |
| Filing → |
| RCUS | SELL | 2026-01-07 | $681K | — | Filing → |
| RCUS | SELL | 2025-12-18 | $688K | — | Filing → |
| RCUS | SELL | 2025-12-05 | $4.1M | — | Filing → |